Standard Biotools (LAB) Net Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 300.00 |
| 10 | Standard Biotools | 256.97 Mn | -219.75 Mn | 10.54 Mn | -7,156.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,556.00 |
| Mar 31, 2026 | 73,713.00 |
| Dec 31, 2025 | -57,607.00 |
| Sep 30, 2025 | -6,267.00 |
| Jun 30, 2025 | 25,725.00 |
| Mar 31, 2025 | 27,467.00 |
| Sep 30, 2024 | -4,528.00 |
| Jun 30, 2024 | -5,678.00 |
| Mar 31, 2024 | -1,325.00 |
| Dec 31, 2023 | 9,060.00 |
| Sep 30, 2023 | -6,781.00 |
| Jun 30, 2023 | -1,164.00 |
| Mar 31, 2023 | -926.00 |
| Dec 31, 2022 | 60,605.00 |
| Sep 30, 2022 | -6,610.00 |
| Jun 30, 2022 | -28,968.00 |
| Mar 31, 2022 | -20,327.00 |
| Sep 30, 2021 | -311.00 |
| Jun 30, 2021 | 511.00 |
| Mar 31, 2021 | -490.00 |